Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Twist Bioscience Corp (TWST) – Twist Bioscience Corp Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Twist Bioscience (TWST) trades at $60.94, up 3.82% today, with a bullish technical signal and strong analyst support. Revenue growth is robust, rising from $132M in 2021 to $392M projected for 2025, though the company remains unprofitable with a net margin of -19.56%. Recent news includes upcoming Q2 2026 earnings and strategic partnerships, while institutional buying activity signals confidence.
The outlook hinges on continued revenue expansion and path to profitability, with upside potential if earnings beat expectations. Key risks include persistent cash burn, competitive pressures, and reliance on biotech funding cycles. Analysts maintain a Moderate Buy rating with a $55.33 price target, slightly below current levels, suggesting cautious optimism amid growth prospects.
Read full analysis

Key Stats

  • Market Cap
    $3.74B
  • Sector
    Health
  • 3M Drawdown
    -23.4%
  • Enterprise Value
    $3.64B
  • Dividend Yield
    -
  • Typical Hold Time
    28 days
$61.24
52W Low: $24.16
10 Sep 2025
52W High: $63.2
22 Apr 2026

Twist Bioscience Corp (TWST) is currently valued at a market capitalization of $3.74B, with an enterprise value of $3.64B. Over the past 52 weeks, Twist Bioscience Corp has traded between a low of $24.16 and a high of $63.2, highlighting its annual price range. Over the past three months, Twist Bioscience Corp has recorded a drawdown of -23.4%, reflecting recent price volatility. On average, investors hold Twist Bioscience Corp for approximately 28 days, indicating typical investor behavior on the platform.

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.


Technical Indicators
|
|
|
Overall Summary
Bearish (8)Neutral (7)Bullish (12)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $3.74B
  • Sector
    Health
  • 3M Drawdown
    -23.4%
  • Enterprise Value
    $3.64B
  • Dividend Yield
    -
  • Typical Hold Time
    28 days
$61.24
52W Low: $24.16
10 Sep 2025
52W High: $63.2
22 Apr 2026

Twist Bioscience Corp (TWST) is currently valued at a market capitalization of $3.74B, with an enterprise value of $3.64B. Over the past 52 weeks, Twist Bioscience Corp has traded between a low of $24.16 and a high of $63.2, highlighting its annual price range. Over the past three months, Twist Bioscience Corp has recorded a drawdown of -23.4%, reflecting recent price volatility. On average, investors hold Twist Bioscience Corp for approximately 28 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!